Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

XiaWei Wei

Showing results (21-30 of 247) with videos related to

Pageof 25
Sort By:
Contrast Media & Molecular Imaging|November 29, 2019
Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based ChemotherapyChaoyue Chen, Hongyu Zhuo, Xiawei Wei, et al.
Precision Clinical Medicine|November 20, 2020
Calling for a united action to defeat COVID-19Madison Overby, Qinqin Pu, Xiawei Wei, et al.
Bone Research|August 15, 2020
Molecular mechanisms and clinical management of cancer bone metastasisManni Wang, Fan Xia, Yuquan Wei, et al.
Molecular Aspects of Medicine|October 7, 2020
The role of oxidized phospholipids in the development of diseaseJi Nie, Jing Yang, Yuquan Wei, et al.
Cellular & Molecular Immunology|October 31, 2019
Epigenetic regulation of macrophages: from homeostasis maintenance to host defenseSiyuan Chen, Jing Yang, Yuquan Wei, et al.
Ebiomedicine|February 24, 2023
Redox signaling in drug-tolerant persister cells as an emerging therapeutic targetZhe Zhang, Yunhan Tan, Canhua Huang, et al.
Precision Clinical Medicine|June 13, 2022
Role of tumor gene mutations in treatment response to immune checkpoint blockadesManni Wang, Liu Yu, Xiawei Wei, et al.
Molecular Cancer|June 10, 2025
Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapyXiuzhu Wu, Haiying Que, Qingfang Li, et al.
Medcomm|November 12, 2021
A dual MET/AXL small-molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironmentChenjing Zhu, Huashan Shi, Min Wu, et al.
Medcomm|March 20, 2023
The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariantsDanyi Ao, Xuemei He, Weiqi Hong, et al.
Pageof 25

Showing results (21-30 of 247) with videos related to

Sort By:
Pageof 25
Contrast Media & Molecular Imaging|November 29, 2019
Contrast-Enhanced MRI Texture Parameters as Potential Prognostic Factors for Primary Central Nervous System Lymphoma Patients Receiving High-Dose Methotrexate-Based ChemotherapyChaoyue Chen, Hongyu Zhuo, Xiawei Wei, et al.
Precision Clinical Medicine|November 20, 2020
Calling for a united action to defeat COVID-19Madison Overby, Qinqin Pu, Xiawei Wei, et al.
Bone Research|August 15, 2020
Molecular mechanisms and clinical management of cancer bone metastasisManni Wang, Fan Xia, Yuquan Wei, et al.
Molecular Aspects of Medicine|October 7, 2020
The role of oxidized phospholipids in the development of diseaseJi Nie, Jing Yang, Yuquan Wei, et al.
Cellular & Molecular Immunology|October 31, 2019
Epigenetic regulation of macrophages: from homeostasis maintenance to host defenseSiyuan Chen, Jing Yang, Yuquan Wei, et al.
Ebiomedicine|February 24, 2023
Redox signaling in drug-tolerant persister cells as an emerging therapeutic targetZhe Zhang, Yunhan Tan, Canhua Huang, et al.
Precision Clinical Medicine|June 13, 2022
Role of tumor gene mutations in treatment response to immune checkpoint blockadesManni Wang, Liu Yu, Xiawei Wei, et al.
Molecular Cancer|June 10, 2025
Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapyXiuzhu Wu, Haiying Que, Qingfang Li, et al.
Medcomm|November 12, 2021
A dual MET/AXL small-molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironmentChenjing Zhu, Huashan Shi, Min Wu, et al.
Medcomm|March 20, 2023
The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariantsDanyi Ao, Xuemei He, Weiqi Hong, et al.
Pageof 25